Cargando…

Baseline patient‐reported outcomes from UNITE: an observational, international, multicentre registry to evaluate hidradenitis suppurativa in clinical practice

BACKGROUND: Hidradenitis suppurativa (HS) is a chronic, inflammatory, skin condition associated with many comorbidities and often has a substantial impact on patients’ lives. OBJECTIVES: To evaluate symptom burden and health‐related quality of life (HRQoL) at baseline in patients with HS in an obser...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kimball, A.B., Crowley, J.J., Papp, K., Calimlim, B., Duan, Y., Fleischer, A.B., Sobell, J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Acne, Rosacea and Hidradenitis Suppurativa
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317945/ https://www.ncbi.nlm.nih.gov/pubmed/31800124 http://dx.doi.org/10.1111/jdv.16132

Ejemplares similares

Primary alterations during the development of hidradenitis suppurativa
por: Dajnoki, Z., et al.
Publicado: (2021)

Real‐world effectiveness of adalimumab in patients with moderate‐to‐severe hidradenitis suppurativa: the 1‐year SOLACE study
por: Gulliver, W., et al.
Publicado: (2021)

Improvement in Hidradenitis Suppurativa and quality of life in patients treated with adalimumab: Real‐world results from the HARMONY Study
por: Hafner, A., et al.
Publicado: (2021)

Surgical outcomes and the impact of major surgery on quality of life, activity impairment and sexual health in hidradenitis suppurativa patients: a prospective single centre study
por: Prens, L.M., et al.
Publicado: (2019)

A novel nicastrin mutation in a three‐generation Dutch family with hidradenitis suppurativa: a search for functional significance
por: Vossen, A.R.J.V., et al.
Publicado: (2020)

Creation of a severity index for hidradenitis suppurativa that includes a validated quality‐of‐life measure: the HIDRAscore
por: Marzano, A.V., et al.
Publicado: (2020)

Weekly adalimumab treatment decreased disease flare in hidradenitis suppurativa over 36 weeks: integrated results from the phase 3 PIONEER trials
por: van der Zee, H.H., et al.
Publicado: (2019)

Long‐term safety and efficacy of trifarotene 50 μg/g cream, a first‐in‐class RAR‐γ selective topical retinoid, in patients with moderate facial and truncal acne
por: Blume‐Peytavi, U., et al.
Publicado: (2019)

Apremilast for moderate hidradenitis suppurativa: no significant change in lesional skin inflammatory biomarkers
por: Vossen, A.R.J.V., et al.
Publicado: (2018)

HIDRAdisk: validation of an innovative visual tool to assess the burden of hidradenitis suppurativa
por: Peris, K., et al.
Publicado: (2019)

Acne relapses: impact on quality of life and productivity
por: Dreno, B., et al.
Publicado: (2019)

The influence of exposome on acne
por: Dréno, B., et al.
Publicado: (2018)

Papulopustular rosacea and rosacea‐like demodicosis: two phenotypes of the same disease?
por: Forton, F.M.N., et al.
Publicado: (2018)

Consensus on the treatment of hidradenitis suppurativa - Brazilian Society of Dermatology
por: Magalhães, Renata Ferreira, et al.
Publicado: (2019)

New treatments and new assessment instruments for Hidradenitis suppurativa
por: van Straalen, Kelsey R., et al.
Publicado: (2022)

Baseline Characteristics from UNITE: An Observational, International, Multicentre Registry to Evaluate Hidradenitis Suppurativa (Acne Inversa) in Clinical Practice
por: Prens, Errol P., et al.
Publicado: (2020)

HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo‐controlled portion of a phase 2 adalimumab study
por: Kimball, A.B., et al.
Publicado: (2015)

An assessment of the relative impact of hidradenitis suppurativa, psoriasis, and obesity on quality of life()()
por: Storer, M.A., et al.
Publicado: (2018)

Impact of hidradenitis suppurativa on work loss, indirect costs and income
por: Tzellos, T., et al.
Publicado: (2018)

Association of hidradenitis suppurativa disease severity with increased risk for systemic comorbidities
por: Crowley, JJ, et al.
Publicado: (2014)

Guidelines for Qualifications of Neurodiagnostic Personnel: A Joint Position Statement of the American Clinical Neurophysiology Society, the American Association of Neuromuscular & Electrodiagnostic Medicine, the American Society of Neurophysiological Monitoring, and ASET—The Neurodiagnostic Society
por: López, Jaime R., et al.
Publicado: (2023)

Retrospective cohort study of pregnancy outcomes in hidradenitis suppurativa
por: Lyon, A.B., et al.
Publicado: (2020)

TNF-α inhibitors in the treatment of hidradenitis suppurativa
por: Savage, Kevin T., et al.
Publicado: (2019)

Cura tu acné : dietas y nuevos tratamientos
por: Hoehn, Gustave H.
Publicado: (1997)

Vulvar cancer in hidradenitis suppurativa
por: Vergeldt, T.F.M., et al.
Publicado: (2022)

Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations
por: Garg, Amit, et al.
Publicado: (2022)

Multimodal management of hidradenitis suppurativa
por: Jemec, Gregor B.E.
Publicado: (2020)

Unmet clinical needs and burden of disease in hidradenitis suppurativa: real‐world experience from EU5 and US
por: Ingram, J.R., et al.
Publicado: (2022)

Treatment of hidradenitis suppurativa resolves associated hematologic abnormalities
por: Morss-Walton, Peyton C., et al.
Publicado: (2022)

Response to: Remission of hidradenitis suppurativa after bariatric surgery
por: Golbari, Nicole Mona, et al.
Publicado: (2018)

Bases para la atención farmacéutica del acné vulgar /
por: Sánchez Alonso, Francisco
Publicado: (2000)

Biologic therapy is not associated with increased COVID-19 severity in patients with hidradenitis suppurativa: Initial findings from the Global Hidradenitis Suppurativa COVID-19 Registry
por: Naik, Haley B., et al.
Publicado: (2022)

Hidradenitis suppurativa in AIDS
por: Khambhati, Ravi, et al.
Publicado: (2010)

Hidradenitis suppurativa and intimacy
por: Jemec, G.
Publicado: (2018)

Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa
por: Gulliver, Wayne, et al.
Publicado: (2016)

Coexistence of Hidradenitis Suppurativa and Steatocystoma Multiplex: Is It a New Variant of Hidradenitis Suppurativa?
por: Fletcher, Joshua, et al.
Publicado: (2021)

Characterizing perimenstrual flares of hidradenitis suppurativa
por: Collier, Erin K., et al.
Publicado: (2020)

The Comorbidity Burden of Hidradenitis Suppurativa in the United States: A Claims Data Analysis
por: Kimball, Alexandra B., et al.
Publicado: (2018)

Tofacitinib shows benefit in conjunction with other therapies in recalcitrant hidradenitis suppurativa patients
por: Savage, Kevin T., et al.
Publicado: (2020)

Methotrexate shows benefit in a subset of patients with severe hidradenitis suppurativa
por: Savage, Kevin T., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gn6i1gu9l02mid7dgn79bshbam